Drug therapy for delirium in terminally ill adult patients
about
Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development.Clinical practice guidelines for delirium management: potential application in palliative care.An analytical framework for delirium research in palliative care settings: integrated epidemiologic, clinician-researcher, and knowledge user perspectivesDelirium diagnosis, screening and managementCognitive impairment in patients with AIDS - prevalence and severity.Frequency and Outcome of Neuroleptic Rotation in the Management of Delirium in Patients with Advanced Cancer.Medication use during end-of-life care in a palliative care centre.Pharmacological interventions for delirium in intensive care patients: a protocol for an overview of reviewsQuality of clinical practice guidelines in delirium: a systematic appraisal.Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trialPharmacovigilance in hospice/palliative care: net effect of haloperidol for delirium.Off-Label Medication Use in the Inpatient Palliative Care Unit.Neuroleptics in the management of delirium in patients with advanced cancer.Loss of melatonin daily rhythmicity is asociated with delirium development in hospitalized older adults.Clinical Assessment and Management of Delirium in the Palliative Care Setting[Interprofessional symptom management at the end of life].
P2860
Q33844380-7483FF27-B6C2-409A-AF92-3F2E05976F6EQ34028016-2EDDA136-5E1D-4C5E-AD1A-9FF9B8C72CE3Q34028023-6E053998-0140-485B-BDA7-B869749B8324Q34171142-CFFA3913-A279-4DE6-9A46-17A23AD98DDFQ35057500-257D5222-1FC3-459F-A5EA-5425E44BA02BQ35862286-66A2687E-40CB-438F-B535-279F70AFCD62Q36123690-E67F420E-AF89-4C34-A5F8-12F43D75A252Q36214472-B5633161-47A6-4630-9D15-47CFBC3C90A0Q36304882-0ECEE872-792E-48EE-A3F0-1336FDD06FF1Q36514404-8B7B3C8B-9804-4DDE-8F87-EB120DE86921Q37293548-5A4B4177-C726-4157-804F-E1E29CAB72FFQ38799557-9E977079-17D8-45BA-B51A-D86863D334A3Q38962532-827F075E-1E56-4F98-9088-2C14DFA70EAAQ41825166-285DAC89-BD73-45BD-B7AE-5F8F62636111Q42182792-2A57524D-2D66-4605-BF29-2BD1FFE6C99BQ50067275-3F24E345-8024-48AD-B7AC-6487DAC2651A
P2860
Drug therapy for delirium in terminally ill adult patients
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Drug therapy for delirium in terminally ill adult patients
@ast
Drug therapy for delirium in terminally ill adult patients
@en
Drug therapy for delirium in terminally ill adult patients
@nl
type
label
Drug therapy for delirium in terminally ill adult patients
@ast
Drug therapy for delirium in terminally ill adult patients
@en
Drug therapy for delirium in terminally ill adult patients
@nl
prefLabel
Drug therapy for delirium in terminally ill adult patients
@ast
Drug therapy for delirium in terminally ill adult patients
@en
Drug therapy for delirium in terminally ill adult patients
@nl
P2093
P2860
P1476
Drug therapy for delirium in terminally ill adult patients
@en
P2093
Adrian Tookman
Baptiste Leurent
Bridget Candy
Kenneth C Jackson
Louise Jones
Michael King
P2860
P356
10.1002/14651858.CD004770.PUB2
P577
2012-11-14T00:00:00Z